骶骨经皮电神经刺激对抗胆碱能治疗难治性膀胱过度活动患者的疗效:一项前瞻性多中心研究。

M Coronas Soucheiron, I Casal Beloy, F N Villalón Ferrero, O Martín Solé, B Capdevila Vilaró, N González Temprano, L Larreina De la Fuente, M García González, M Carbonell Pradas, S Pérez Bertólez, X Tarrado Castellarnau, L García Aparicio, I Somoza Argibay
{"title":"骶骨经皮电神经刺激对抗胆碱能治疗难治性膀胱过度活动患者的疗效:一项前瞻性多中心研究。","authors":"M Coronas Soucheiron,&nbsp;I Casal Beloy,&nbsp;F N Villalón Ferrero,&nbsp;O Martín Solé,&nbsp;B Capdevila Vilaró,&nbsp;N González Temprano,&nbsp;L Larreina De la Fuente,&nbsp;M García González,&nbsp;M Carbonell Pradas,&nbsp;S Pérez Bertólez,&nbsp;X Tarrado Castellarnau,&nbsp;L García Aparicio,&nbsp;I Somoza Argibay","doi":"10.54847/cp.2023.04.14","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).</p><p><strong>Materials and methods: </strong>A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed.</p><p><strong>Results: </strong>66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area).</p><p><strong>Conclusions: </strong>S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.</p>","PeriodicalId":94306,"journal":{"name":"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study.\",\"authors\":\"M Coronas Soucheiron,&nbsp;I Casal Beloy,&nbsp;F N Villalón Ferrero,&nbsp;O Martín Solé,&nbsp;B Capdevila Vilaró,&nbsp;N González Temprano,&nbsp;L Larreina De la Fuente,&nbsp;M García González,&nbsp;M Carbonell Pradas,&nbsp;S Pérez Bertólez,&nbsp;X Tarrado Castellarnau,&nbsp;L García Aparicio,&nbsp;I Somoza Argibay\",\"doi\":\"10.54847/cp.2023.04.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).</p><p><strong>Materials and methods: </strong>A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed.</p><p><strong>Results: </strong>66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area).</p><p><strong>Conclusions: </strong>S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.</p>\",\"PeriodicalId\":94306,\"journal\":{\"name\":\"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54847/cp.2023.04.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54847/cp.2023.04.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:确定骶经皮电神经刺激(S-TENS)是否是抗胆碱能药物(Achs)难治性患者的有效治疗方法。材料和方法:对2018年至2021年接受S-TENS治疗的Achs难治性膀胱过度活动症(OB)患者进行前瞻性多中心研究。S-TENS应用时间超过3个月。使用排尿日历和儿童下尿路症状评分(PLUTSS)评估症状进展,排除问题3和问题4(涉及遗尿),以便仅分析日间症状的进展(LUTS变量)。结果:纳入66名患者,其中50%为女性,平均年龄9.5岁(范围:5-15岁)。S-TENS显著降低PLUTSS(19.1基线vs.9.5最终,P结论:S-TENS在短期内对Achs难治性OB患者有效且安全。需要进一步研究评估长期疗效和潜在复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study.

Objective: To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).

Materials and methods: A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed.

Results: 66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area).

Conclusions: S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信